Global, regional, and national burden of sudden infant death syndrome, 1990-2021: a comprehensive analysis of GBD 2021 data with insights into the impact during the COVID-19 pandemic
- PMID: 40630720
- PMCID: PMC12234550
- DOI: 10.3389/fped.2025.1606910
Global, regional, and national burden of sudden infant death syndrome, 1990-2021: a comprehensive analysis of GBD 2021 data with insights into the impact during the COVID-19 pandemic
Abstract
Background: Sudden infant death syndrome (SIDS) remains a leading cause of infant mortality globally. Although the global burden has generally declined over recent decades, the COVID-19 pandemic may have influenced these trends. This study investigates whether the global SIDS burden has changed, particularly during the COVID-19 pandemic.
Methods: Data from the Global Burden of Disease (GBD) 2021 study were analyzed to estimate SIDS mortality and disability-adjusted life years (DALYs) globally, regionally, and nationally. Rates were stratified by sex, age group, socio-demographic index (SDI), and health system level. Projections were made using the Bayesian Age-Period-Cohort model and the the autoregressive integrated moving average (ARIMA) model.
Results: In 2021, global SIDS deaths totaled 30,608, with a mortality rate of 24.16 per 100,000 infants (95% UI, 14.06-32.44). Global DALYs were 2,746,174, at a rate of 2,167.56 per 100,000 infants (95% UI, 1,261.44-2,909.59). Mortality and DALYs rates decreased by 59% from 1990 to 2021, with marked regional differences. Regions with Low SDI and Minimal health systems, particularly Sub-Saharan Africa, had the highest burden, while higher SDI and advanced health system regions reported significant declines. Male infants aged 1-5 months showed higher rates than females. Despite a global decline during the pandemic, temporary increases occurred in countries including China, the Russian Federation, and Monaco. Projections suggest continued declines, predicting a mortality rate of 16.86 per 100,000 infants and DALYs rate of 1,400.41 per 100,000 infants by 2035.
Conclusions: The global SIDS burden has consistently declined since 1990, including during COVID-19, yet significant regional disparities remain. Enhanced healthcare interventions and targeted public health initiatives are crucial, particularly in regions with Low SDI and Minimal health system resources.
Keywords: COVID-19; disability-adjusted life years; global burden of disease; mortality; socio-demographic index; sudden infant death syndrome.
© 2025 Sun, Peng, Chen, Qin, Ren and Cheng.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Global, regional, and national burden of sudden infant death syndrome and the impact of COVID-19: a trend and health inequality analysis based on the global burden of disease study 2021.Front Pediatr. 2025 Jul 25;13:1623238. doi: 10.3389/fped.2025.1623238. eCollection 2025. Front Pediatr. 2025. PMID: 40787009 Free PMC article.
-
Global pattern, trend and cross-country inequalities of inguinal, femoral, and abdominal hernia among individuals aged 60 and above from 1990 to 2021 and projections until 2040: a population-based study.Surg Endosc. 2025 Jul;39(7):4335-4344. doi: 10.1007/s00464-025-11810-5. Epub 2025 May 28. Surg Endosc. 2025. PMID: 40437076
-
Hepatoblastoma regional trends: dynamic SDI & joinpoint regression analysis.BMC Cancer. 2025 Jul 5;25(1):1148. doi: 10.1186/s12885-025-14566-2. BMC Cancer. 2025. PMID: 40618033 Free PMC article.
-
Burden of knee osteoarthritis in China and globally: 1990-2045.BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8. BMC Musculoskelet Disord. 2025. PMID: 40598022 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources